Study of the Cell Response in the Tear Film After Overnight Contact Lens Wear (CORNWALL)
6 mars 2013 uppdaterad av: CIBA VISION
Polymorphonuclear Leukocyte Response During Overnight Lens Wear
The purpose of this study was to count and analyze the white blood cells in tear samples collected from study participants following sleep.
The results from contact lens wearers were compared with the results from non-contact lens wearers.
Studieöversikt
Status
Avslutad
Betingelser
Detaljerad beskrivning
The objective of the study was to determine and compare the relative oxidative response of polymorphonuclear neutrophils (PMNs), the relative cell adhesion response of PMNs, and the leukocyte population in tear samples collected from contact lens wearers and non-contact lens wearers.
Tear samples were collected via a binocular eye-wash.
The samples were processed, and a cell count was performed using a hemacytometer.
Flow cytometry was used to determine the expression of different PMN cell markers before and after stimulation with bacterial lipopolysaccharide (LPS).
Studietyp
Interventionell
Inskrivning (Faktisk)
65
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Ontario
-
Waterloo, Ontario, Kanada, N2L 3G1
- University of Waterloo Centre for Contact Lens Research
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
17 år och äldre (Barn, Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- 17 years of age or older.
- Ocular examination in the last two years.
- Has up-to-date spectacles.
Falls into one of the following three categories:
- Adapted wearer of Lotrafilcon A contact lenses
- Adapted wearer of Lotrafilcon B contact lenses
- Does not wear contact lenses
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Ocular disease
- Systemic or topical medications that may affect ocular health.
- Known sensitivity to diagnostic pharmaceuticals used in study.
- Uses artificial tears and/or rewetting drops.
- Wears contact lenses on an overnight basis for more than one night per week.
- Other protocol-defined exclusion criteria may apply.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Lotrafilcon A
Lotrafilcon A contact lenses worn on a daily wear basis for 1 week, followed by 8 hours overnight wear in a replacement pair.
After a 12-hour washout period, a new pair of lotrafilcon A contact lenses were dispensed for 4 weeks of daily wear, followed by 8 hours overnight wear.
|
Commercially marketed, silicone hydrogel, single-vision contact lens FDA-approved for daily and extended (overnight) wear for up to 30 nights.
Andra namn:
Hydrogen peroxide-based contact lens care system for nightly cleaning and disinfection of study lenses
Andra namn:
|
|
Aktiv komparator: Lotrafilcon B
Lotrafilcon B contact lenses worn on a daily wear basis for 1 week, followed by 8 hours overnight wear in a replacement pair.
After a 12-hour washout period, a new pair of lotrafilcon B contact lenses were dispensed for 4 weeks of daily wear, followed by 8 hours overnight wear.
|
Hydrogen peroxide-based contact lens care system for nightly cleaning and disinfection of study lenses
Andra namn:
Commercially marketed, silicone hydrogel, single-vision contact lens FDA-approved for daily or extended (overnight) wear up to 6 nights.
Andra namn:
|
|
Inget ingripande: No lens wear
No contact lens wear for the duration of the study.
One 8-hour sleep at 1 week, followed by an 8-hour sleep 4 weeks later.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Leukocyte Population
Tidsram: Week 5
|
A tear sample was collected after 8 hours of sleep using an ocular surface cell collection apparatus (OSCCA).
Different types of white blood cells (leukocytes) were identified, which included neutrophils, monocytes, and lymphocytes.
The total amount of leukocytes for contact lens wearers and non-lens wearers is presented.
Potential differences in leukocyte count between lens wearers and non-lens wearers may indicate a different immune response.
|
Week 5
|
|
Relative Cell Adhesion Response of Polymorphonuclear Leukocytes (PMNs)
Tidsram: Week 5
|
A tear sample was collected after 8 hours of sleep using an ocular surface cell collection apparatus (OSCCA) and analyzed on a flow cytometer.
CD54 is a protein typically found in the cell membrane of leukocytes, which up-regulates during inflammation and promotes cell adhesion.
Cell adhesion response is reported as a ratio of stimulated to non-stimulated samples.
|
Week 5
|
|
Relative Oxidative Response of Polymorphonuclear Leukocytes (PMNs)
Tidsram: Week 5
|
A tear sample was collected after 8 hours of sleep using an ocular surface cell collection apparatus (OSCCA) and analyzed on a flow cytometer.
Oxidative response is reported as a ratio of activated to non-activated samples.
DCF (dichlorofluorescein diacetate) is a molecular probe that measures the oxidative burst.
Upon stimulation, the PMNs synthesize reactive oxygen species, such as superoxide or hydrogen peroxide, which is detected by the probe.
Differences in the oxidative response between contact lens wearers and non-lens wearers is indicated by a shift in the ratio (stimulated/unstimulated).
|
Week 5
|
|
Change From Week 1 in Leukocyte Population at Week 5
Tidsram: Week 1, Week 5
|
A tear sample was collected after 8 hours of sleep using an ocular surface cell collection apparatus (OSCCA).
Different types of white blood cells (leukocytes) were identified, which included neutrophils, monocytes, and lymphocytes.
The difference between total leukocytes for contact lens wearers and non-lens wearers (Week 5 minus Week 1) is presented.
|
Week 1, Week 5
|
|
Change From 1 Week in Relative Cell Adhesion Response of PMNs at Week 5
Tidsram: Week 1, Week 5
|
A tear sample was collected after 8 hours of sleep using an ocular surface cell collection apparatus (OSCCA) and analyzed on a flow cytometer.
Cell adhesion response is reported as a ratio of activated to non-activated samples.
The difference between the ratio data for contact lens wearers and non-lens wearers (Week 5 minus Week 1) is presented.
|
Week 1, Week 5
|
|
Change From Week 1 in Relative Oxidative Response of PMNs at Week 5
Tidsram: Week 1, Week 5
|
A tear sample was collected after 8 hours of sleep using an ocular surface cell collection apparatus (OSCCA) and analyzed on a flow cytometer.
Oxidative response is reported as a ratio of activated to non-activated samples.
The difference between the ratio data for contact lens wearers and non-lens wearers (Week 5 minus Week 1) is presented.
|
Week 1, Week 5
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Lyndon Jones, PhD FCOptom FAAO, Director, Centre for Contact Lens Research, School of Optometry, University of Waterloo
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 maj 2011
Primärt slutförande (Faktisk)
1 januari 2012
Avslutad studie (Faktisk)
1 januari 2012
Studieregistreringsdatum
Först inskickad
9 juni 2011
Först inskickad som uppfyllde QC-kriterierna
22 juni 2011
Första postat (Uppskatta)
23 juni 2011
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
8 mars 2013
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
6 mars 2013
Senast verifierad
1 mars 2013
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- P-373-C-102
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .